Friday, May 10, 2013

Doing it for the Kids

Save the Children teams up with GlaxoSmithKline
The international charity Save the Children is embarking on a partnership with a multinational drug company in a controversial move which the two organisations say is designed to save a million children's lives.
A decade ago, Save the Children was among the development organisations lambasting GlaxoSmithKline, one of the world's biggest drug companies, for its high price tags on HIV drugs for the developing world. The initiative launched by the two organisations on Thursday in Kenya will see Save the Children with a seat on the R&D board, advising on new products for the poorest countries, while GSK also pays for the training of more healthcare workers who will dispense medicines and give vaccines.
Let me guess.... medicines and vaccines produced by GSK, right?

Not only are they patenting STC's excellent suggestions for product improvements- they are going to make huge profits selling those new versions and silence one of their most credible critics doing it.

How very kind of them.